Horizon 2020 Project: NoCanTher

RCL is proud to be part of a team of leading European universities, SMEs and hospitals that have recently been awarded a European Commission Horizon 2020 grant to develop a multimodal nanomedicine therapy for pancreatic cancer. The project aims to run clinical trials using RCL hyperthermia equipment by 2020. Further information can be found on the NoCanTher website.